BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 250.00
+30.00 (13.64%)
At close: Jul 29, 2025, 3:30 PM KST
BioInfra Life Science Company Description
BioInfra Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.
Its portfolio includes cancer screening test technology, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment.
The company was founded in 2001 and is based in Seoul, South Korea.
BioInfra Life Science Inc.
| Country | South Korea |
| Founded | 2001 |
| Industry | Surgical and Medical Instruments and Apparatus |
| CEO | Dukyun Lee |
Contact Details
Address: Daehak-ro 49 Seoul, 03127 South Korea | |
| Phone | 82 2 6012 0333 |
| Website | bioinfra.co.kr |
Stock Details
| Ticker Symbol | 266470 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dukyun Lee | Chief Executive Officer |